@misc{patel_shah_bambharoliya_patel_patel_patel_bhavsar_padhiyar_patel_mahavar_et al._2024, title={A Review on the Development of Novel Heterocycles as α-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus}, volume={20}, ISSN={["1875-6638"]}, DOI={10.2174/0115734064264591231031065639}, abstractNote={Abstract: One of the most effective therapeutic decencies in the treatment of Type 2 Diabetes Mellitus is the inhibition of α-glucosidase enzyme, which is present at the brush border of the intestine and plays an important role in carbohydrate digestion to form mono-, di-, and polysaccharides. Acarbose, Voglibose, Miglitol, and Erniglitate have been well-known α-glucosidase inhibitors in science since 1990. However, the long synthetic route and side effects of these inhibitors forced the researchers to move their focus to innovate simple and small heterocyclic scaffolds that work as excellent α-glucosidase inhibitors. Moreover, they are also effective against the postprandial hyperglycemic condition in Type 2 Diabetes Mellitus. In this aspect, this review summarizes recent progress in the discovery and development of heterocyclic molecules that have been appraised to show outstanding inhibition of α-glucosidase to yield positive effects against diabetes.}, number={5}, journal={MEDICINAL CHEMISTRY}, author={Patel, Prexa and Shah, Drashti and Bambharoliya, Tushar and Patel, Vidhi and Patel, Mehul and Patel, Dharti and Bhavsar, Vashisth and Padhiyar, Shantilal and Patel, Bhavesh and Mahavar, Anjali and et al.}, year={2024}, pages={503–536} }
 @article{mehta_patel_patel_patel_shah_rathod_shah_patel_bambharoliya_2024, title={Molecular Docking, <i>In silico</i> ADMET Study and Synthesis of Quinoline Derivatives as Dihydrofolate Reductase (DHFR) Inhibitors: A Solvent-free One-pot Green Approach through Sonochemistry}, volume={21}, ISSN={["1875-628X"]}, DOI={10.2174/1570180820666221107090046}, abstractNote={
Background:
Quinoline derivatives have evinced their biological importance in targeting bacteria
by inhibiting Dihydrofolate reductase. H2SO4 was successfully applied as an acid catalyst for a
green, efficient, and one-pot solvent-free synthesis of quinoline derivatives using sonochemistry approach
from various aromatic amines and glycerol with affording yield up to 96% within 6-10 min.
}, number={3}, journal={LETTERS IN DRUG DESIGN & DISCOVERY}, author={Mehta, Meshwa and Patel, Stuti and Patel, Ashish and Patel, Yug and Shah, Drashti and Rathod, Keyur and Shah, Umang and Patel, Mehul and Bambharoliya, Tushar}, year={2024}, pages={504–519} }
 @misc{patel_patel_shah_patel_savaliya_bambharoliya_shah_mahavar_patel_2024, title={Unlocking the Potential: A Comprehensive Review for the Synthesis of Benzofuran Derivatives}, volume={11}, ISSN={["2213-347X"]}, DOI={10.2174/0122133461272081231102061911}, abstractNote={
Abstract:
Benzofuran, a versatile heterocyclic compound, has gained considerable attention in
recent years due to its diverse biological activities, distinctive structural characteristics, broad synthetic
approaches, and extensive applications. The growing potential inherent in benzofuran encourages
many researchers to address the challenges of the synthesis of its framework. This comprehensive
review aims to provide a detailed overview of the recent advancements in the synthesis
of diverse benzofuran derivatives, highlighting innovative strategies, synthetic methodologies, and
significant breakthroughs in the field. The synthetic methodologies are classified as metalcatalyzed
routes, green-solvent-based routes, microwave-assisted methods, catalyst-free and solvent-
free methods, and a miscellaneous group of routes. This categorization in review provides an
easy means for the reader to rationally select the best possible synthetic method for benzofuran
derivatives. In addition, it explores the use of different solvents and catalysts in benzofuran synthesis,
which serves as a valuable resource for chemists, researchers, and scientists involved in pharmaceutical
and allied sciences. Overall, this review provides a comprehensive overview of the
synthesis of benzofuran scaffolds and complies with all the significant developments in the synthetic
routes of benzofuran, which will be useful for researchers interested in the development of
new benzofuran-based molecules.
}, number={1}, journal={CURRENT GREEN CHEMISTRY}, author={Patel, Krina and Patel, Heli and Shah, Drashti and Patel, Dharti and Savaliya, Neel and Bambharoliya, Tushar and Shah, Ashish and Mahavar, Anjali and Patel, Ashish}, year={2024}, pages={12–36} }
 @misc{patel_shah_patel_patel_mehta_bambharoliya_2023, title={A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease}, volume={24}, ISSN={["1873-5592"]}, DOI={10.2174/1389450124666221213114500}, abstractNote={
Abstract:
Alzheimer's Disease (AD), affecting a large population worldwide, is characterized by the old population's loss of memory and learning ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed to treat AD, including naturally-derived inhibitors, synthetic analogs, and hybrids. Acetylcholinesterase (AChE) has obtained a re-newed interest as a therapeutic target in Alzheimer's disease (AD) due to increased neural cells' function by increasing the concentration of acetylcholine. In this review, we reported the recent de-velopment of novel heterocyclic compounds such as coumarin-benzotriazole hybrids, carbazole de-rivatives, tacrine conjugates, N-benzyl-piperidine-aryl-acyl hydrazones hybrid, spiropyrazoline de-rivatives, coumarin-dithiocarbamate hybrids, etc., as AChE inhibitors for the treatment of Alz-heimer disease. All the bioactive compounds show an effect on different cells and interact simulta-neously with the catalytic active site (CAS) and peripheral anionic site (PAS) of AChE with a nar-row range of IC50 values from 0.4 nm to 88.21 μm using Ellman’s in vitro AChE assay method and show high BBB permeability in vitro. In addition, the in vitro fluorescence assay study using Am-plex Red assay kits revealed that all the compounds could inhibit self-induced β-amyloid (Aβ) ag-gregation with the highest inhibition range from 31.4 to 82%. Furthermore, most of the compounds show a low toxicity profile during in vivo studies. The results suggest that all the compounds consti-tute promising leads for the AChE targeted approach for Alzheimer’s disease.
}, number={3}, journal={CURRENT DRUG TARGETS}, author={Patel, Ashish and Shah, Drashti and Patel, Yug and Patel, Stuti and Mehta, Meshwa and Bambharoliya, Tushar}, year={2023}, pages={225–246} }
 @article{patel_bambharoliya_shah_patel_patel_shah_patel_mahavar_patel_2023, title={Emerging green synthetic routes for thiazole and its derivatives: Current perspectives}, ISSN={["1521-4184"]}, DOI={10.1002/ardp.202300420}, abstractNote={Abstract}, journal={ARCHIV DER PHARMAZIE}, author={Patel, Maitri and Bambharoliya, Tushar and Shah, Drashti and Patel, Krina and Patel, Mehul and Shah, Umang and Patel, Swayamprakash and Mahavar, Anjali and Patel, Ashish}, year={2023}, month={Nov} }
 @misc{patel_patel_patel_patel_bambharoliya_2023, title={Mini Review on Cariprazine: A Promising Antipsychotic Agent}, volume={22}, ISSN={["1996-3181"]}, url={https://doi.org/10.2174/1871527321666220324121935}, DOI={10.2174/1871527321666220324121935}, abstractNote={Abstract:Cariprazine is a piperazine derivative approved by the USFDA in 2015 as a novel atypical antipsychotic drug (APD) to treat adults with schizophrenia and bipolar manic or mixed episodes in adults. However, due to the partial agonist action on dopamine D2, D3 receptors, and serotonin 5-HT1A receptors as well as the antagonist effect on 5-HT2A, 5-HT2B, and H1 receptors, cariprazine differs pharmacologically from other APDs, both typical and atypical. Moreover, cariprazine also has a unique pharmacokinetic profile due to the formation of two clinically significant metabolites: desmethyl-cariprazine (DCAR) and desmethyl-cariprazine (DDCAR). They are eliminated by CYP3A4 and also, to a lesser extent, by CYP2D6. Here, we also review the effectiveness, safety, as well as current clinical update of cariprazine in bipolar I disorder associated with/without mania and schizophrenia through randomized and post-hoc analysis. The potential benefits of cariprazine as a promising therapeutic alternative in addressing major clinical requirements for better therapy of such severe neuropsychiatric conditions were demonstrated in this summarized review study.}, number={2}, journal={CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS}, author={Patel, Ashish and Patel, Arya and Patel, Darshini and Patel, Krina and Bambharoliya, Tushar}, year={2023}, pages={226–236} }
 @article{patel_bambharoliya_shah_patel_savaliya_patel_patel_bhavsar_patel_patel_et al._2023, title={Recent Progress for the Synthesis of ss-Carboline Derivatives - an Update}, ISSN={["1563-5333"]}, DOI={10.1080/10406638.2023.2180525}, abstractNote={AbstractAbstractThe β-Carboline and its derivatives are privileged heterocyclic motifs and important building blocks in the field of medicinal chemistry due to their remarkable pharmacological potentialities and their derivatives have attracted a great deal of interest due to their wide range of biological activities. β-Carboline contains tricyclic pyrido[3,4-b]indole moiety in their structure. The growing potential inherent in them encourages many researchers to address the challenges of the synthesis of β-Carboline framework. As a result, many methodologies have been developed to synthesize this important class of compounds. The present review is mainly an attempt to present the research work reported in the recent scientific literature focusing on different synthetic methods of β-Carboline and related derivatives.Keywords: β-Carbolinepictet-spengler cyclizationpyrido[34-b]indoleHeterocycle Disclosure statementNo potential conflict of interest was reported by the author(s).}, journal={POLYCYCLIC AROMATIC COMPOUNDS}, author={Patel, Vidhi and Bambharoliya, Tushar and Shah, Drashti and Patel, Yug and Savaliya, Neel and Patel, Yash and Patel, Riddhisiddhi and Bhavsar, Vashisth and Patel, Harnisha and Patel, Mehul and et al.}, year={2023}, month={Feb} }
 @misc{shah_bambharoliya_patel_patel_patel_nagani_bhavsar_mahavar_patel_2023, title={Sustainable Synthesis of Phenazines: A Review of Green Approaches}, volume={27}, ISSN={["1875-5348"]}, DOI={10.2174/0113852728257006230921091216}, abstractNote={
Abstract:
Owing to its momentous significance in the development of new medications, phenazine,
and its analogues are successful heterocyclic scaffolds as well as essential building blocks for
developing physiologically active chemicals. Traditionally, phenazine and its derivatives have been
synthesized using chemical methods that involve toxic organic solvents, dangerous reagents, and
the risk of hazardous metal contamination in the final products. These drawbacks have significantly
limited the widespread application of phenazine derivatives in therapeutic treatments and the
pharmaceutical industry. Consequently, there is a growing demand for environmentally friendly
methods that can address these challenges with less environmental damage. As a result, it is now
possible to employ green and highly efficient methods for the synthesis of phenazine and its derivatives.
These methods include mechanosynthesis, solvent-free and catalyst-free synthesis, green solventbased
synthesis, ultrasound-assisted synthesis, microwave-assisted synthesis, and other similar approaches. In
light of the fact that the phenazine backbone is a widely present biologically active component and the growing
need to decrease the use of hazardous solvents, catalysts, and energy, this review has provided a summary of
various sustainable and facile synthetic strategies of phenazine derivatives.
}, number={13}, journal={CURRENT ORGANIC CHEMISTRY}, author={Shah, Drashti and Bambharoliya, Tushar and Patel, Dharti and Patel, Krina and Patel, Niyati and Nagani, Afzal and Bhavsar, Vashisth and Mahavar, Anjali and Patel, Ashish}, year={2023}, pages={1143–1163} }
 @article{shah_patel_patel_mehta_patel_bhimani_bambharoliya_2023, title={Ultrasound-Assisted Synthesis of Benzimidazole Derivatives: A Catalyst-Free Green Chemistry Approach}, volume={59}, ISSN={["1608-3393"]}, DOI={10.1134/S1070428023080146}, number={8}, journal={RUSSIAN JOURNAL OF ORGANIC CHEMISTRY}, author={Shah, Drashti and Patel, Ashish and Patel, Stuti and Mehta, Meshwa and Patel, Yug and Bhimani, Bhargav and Bambharoliya, Tushar}, year={2023}, month={Aug}, pages={1397–1406} }
 @misc{patel_patel_mehta_patel_patel_shah_patel_shah_patel_patel_et al._2022, title={A review on synthetic investigation for quinoline- recent green approaches}, volume={15}, ISSN={["1751-7192"]}, url={https://publons.com/publon/51628205/}, DOI={10.1080/17518253.2022.2064194}, abstractNote={ABSTRACT Quinolines are a prominent heterocyclic motif and crucial building blocks in creating physiologically active compounds. Due to the fast development of novel medicines with a quinoline nucleus, numerous research papers have been published in a short amount of time. Therefore, to comprehend the present state of the quinoline nucleus in medicinal chemistry science, it is necessary to combine new information with older data. So far, several traditional synthesis techniques have been reported in the literature to synthesize this scaffold. Pfitzinger, Gould–Jacob, Friedlander, Skraup, Doebner–von Miller, and Conrad–Limpach are examples of old synthetic methods. However, they need expensive and demanding conditions, such as high temperature, the use of non-biodegradable chemical compounds degrade the ecosystem, create irritation or harm as pollutants, and represent a threat to the environment. However, traditional synthesis processes need a difficult and time-consuming apparatus set-up, resulting in high costs and pollutants. As a result, scientists are presently developing new and innovative techniques to decrease the use of chemicals, solvents, and catalysts, which are detrimental to both humans and the environment. Therefore, we have attempted to shed light in this current review on various reactions to produce quinolines and their derivatives using various green synthetic methods. GRAPHICAL ABSTRACT}, number={2}, journal={GREEN CHEMISTRY LETTERS AND REVIEWS}, author={Patel, Ashish and Patel, Stuti and Mehta, Meshwa and Patel, Yug and Patel, Rushi and Shah, Drashti and Patel, Darshini and Shah, Umang and Patel, Mehul and Patel, Swayamprakash and et al.}, year={2022}, month={Apr}, pages={336–371} }
 @misc{patel_vanecha_patel_patel_shah_bambharoliya_2022, title={Development of Natural Bioactive Alkaloids: Anticancer Perspective}, volume={22}, ISSN={["1875-5607"]}, url={https://doi.org/10.2174/1389557521666210712111331}, DOI={10.2174/1389557521666210712111331}, abstractNote={
Abstract:
Cancer is a frightful disease that still poses a 'nightmare' worldwide, causing millions of
casualties annually imposing one of the human race's greatest health-care challenges that entail a
pragmatic treatment strategy. Plants are repositories for new chemical entities and have a promising
cancer research path, supplying 60% of the anticancer agents currently used. However, plants and
plant-derived products revolutionize the field, as they are quick, cleaner, eco-friendly, low-cost, effective,
and less toxic than conventional treatment methods.
Alkaloids are important chemical compounds that serve as a rich reservoir for drug discovery and development.
However, some alkaloids derived from natural herbs display anti-proliferation and antimetastatic
activity on different forms of cancer both in vitro and in vivo. Alkaloids have also been
widely formulated as anticancer medications, such as camptothecin and vinblastine. Based on the information
in the literature, this review focuses on the naturally-derived bioactive alkaloids with prospective
anticancer properties. Still, more research and clinical trials are required before final recommendations
can be made on specific alkaloids.
}, number={2}, journal={MINI-REVIEWS IN MEDICINAL CHEMISTRY}, publisher={Bentham Science Publishers Ltd.}, author={Patel, Ashish and Vanecha, Ravi and Patel, Jay and Patel, Divy and Shah, Umang and Bambharoliya, Tushar}, year={2022}, pages={200–212} }
 @article{patel_gandhi_shah_patel_chhatbar_shah_patel_patel_bambharoliya_2022, title={In silico Study and Solvent-free one-pot Synthesis of Tetrahydropyrimidine derivatives by Mechanochemistry Approach for Targeting Human Neutrophil Elastase against Lung Cancer}, volume={18}, ISSN={["1875-6697"]}, DOI={10.2174/1573409918666220622232501}, abstractNote={
Background:
Pyrimidine derivative has evinced its biological importance in targeting
lung cancer by inhibiting neutrophil elastase.
}, number={4}, journal={CURRENT COMPUTER-AIDED DRUG DESIGN}, author={Patel, Ashish and Gandhi, Karan and Shah, Sweta and Patel, Darshan and Chhatbar, Shreyas and Shah, Drashti and Patel, Stuti and Patel, Harnisha and Bambharoliya, Tushar}, year={2022}, pages={293–306} }
 @misc{patel_patel_mehta_patel_langaliya_bhalodiya_bambharoliya_2022, title={Recent Update on the Development of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors: A Promising Target for the Treatment of Parkinson's Disease}, volume={18}, ISSN={["1875-6638"]}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85131678836&partnerID=MN8TOARS}, DOI={10.2174/1573406418666220215122136}, abstractNote={
Abstract:
Parkinson’s disease is a relatively common neurological disorder with incidence increasing
with age. Since current medications only relieve the symptoms and do not change the course of
the disease, therefore, finding disease-modifying therapies is a critical unmet medical need. However,
significant progress in understanding how genetics underpins Parkinson's disease (PD) has opened
up new opportunities for understanding disease pathogenesis and identifying possible therapeutic
targets. One such target is leucine-rich repeat kinase 2 (LRRK2), an elusive enzyme implicated in
both familial and idiopathic PD risk. As a result, both academia and industry have promoted the development
of potent and selective inhibitors of LRRK2. In this review, we have summarized recent
progress in the discovery and development of LRKK2 inhibitors as well as the bioactivity of several
small-molecule LRRK2 inhibitors that have been used to inhibit LRRK2 kinase activity in vitro or in
vivo.
}, number={7}, journal={MEDICINAL CHEMISTRY}, author={Patel, Ashish and Patel, Stuti and Mehta, Meshwa and Patel, Yug and Langaliya, Dhruv and Bhalodiya, Shyam and Bambharoliya, Tushar}, year={2022}, pages={757–771} }
 @misc{patel_shah_shah_bambharoliya_patel_panchal_parikh_nagani_patel_vaghasiya_et al._2021, title={A Review on the Synthetic Approach of Marinopyrroles: A Natural Anti-tumor Agent from the Ocean}, volume={18}, ISSN={["1875-6255"]}, url={https://publons.com/publon/33252564/}, DOI={10.2174/1570178617999200718004012}, abstractNote={Natural products play an important role in various drug discovery and development approaches. They are known to be the rich resources for the identification of new chemical entities (NCEs) intended to treat various diseases. Many drugs have been discovered and developed from natural sources. Indeed, collaborative efforts involving biologists as well as organic, medicinal, and phytochemists usually facilitate the identification of potent NCEs derived from natural sources. Over the past 20 years, more than 50% of NCEs have been derived either from marine sources or synthetic/ semisynthetic derivatives of natural products. Indeed, many drug molecules have been designed by considering natural products as the starting scaffold. The first bis-pyrrole alkaloid derivative of marinopyrroles was obtained from the marine-derived streptomycete species. In the laboratory, it can be synthesized via Clauson-Kaas and Friedel-Crafts arylation as well as copper-mediated N-arylation process under microwave irradiation. The marinopyrrole A (±)-28 was discovered to overcome resistance against human cancer cells by antagonizing B-cell lymphoma extra-large (Bcl-xL) and induced myeloid leukaemia cell (Mcl-1). In this review, we elaborated on various synthetic pathways of marinopyrroles possessing anti-cancer potential, which could encourage researchers to discover promising anti-tumor agents.}, number={4}, journal={LETTERS IN ORGANIC CHEMISTRY}, author={Patel, Ashish and Shah, Hirak and Shah, Umang and Bambharoliya, Tushar and Patel, Mehul and Panchal, Ishan and Parikh, Vruti and Nagani, Afzal and Patel, Harnisha and Vaghasiya, Jitendra and et al.}, year={2021}, pages={251–264} }
 @article{zhang_bambharoliya_xie_liu_celik_wang_akkus_king_2021, title={A hybrid vascular graft harnessing the superior mechanical properties of synthetic fibers and the biological performance of collagen filaments}, volume={118}, ISSN={["1873-0191"]}, url={https://publons.com/publon/37769973/}, DOI={10.1016/j.msec.2020.111418}, abstractNote={Tissue-engineered small caliber vascular grafts have attracted much research attention as a viable alternative to traditional vascular grafts with their biocompatibility and potential to achieve complete healing. However, the major challenge is to fabricate a scaffold with both satisfactory mechanical properties and fast endothelialization. In this study, a hybrid tubular vascular tissue engineered scaffold has been circular-knitted using novel electrochemically aligned collagen (ELAC) filaments plied together with traditional poly(lactic acid) (PLA) yarn. The collagen component was able to promote the recruitment and proliferation of endothelial cells by increasing the initial cell adhesion 10-fold and the eventual cell population 3.2 times higher than the PLA scaffold alone. At the same time, the PLA yarn was able to provide sufficient mechanical strength and structural stability, as well as facilitate scaffold fabrication on high speed textile production equipment. The tubular hybrid scaffold exhibited excellent bursting strength (1.89 ± 0.43 MPa) and suture retention strength (10.86 ± 0.49 N), and had comparable compliance (3.98 ± 1.94%/100 mmHg) to that of the coronary artery (3.8 ± 0.3%/100 mmHg) under normotensive pressure. With its excellent mechanical and biological performance, this prototype hybrid scaffold is a promising candidate for the construction of a clinically successful and easily translatable tissue-engineered small caliber vascular graft.}, journal={MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS}, publisher={Elsevier BV}, author={Zhang, Fan and Bambharoliya, Tushar and Xie, Yu and Liu, Laijun and Celik, Hakan and Wang, Lu and Akkus, Ozan and King, Martin W.}, year={2021}, month={Jan} }
 @article{patel_shah_patel_patel_soni_nagani_parikh_shah_bambharoliya_2021, title={Benzimidazole as Ubiquitous Structural Fragment: An Update on Development of its Green Synthetic Approaches}, volume={18}, ISSN={["1875-6298"]}, url={https://doi.org/10.2174/1570193X17999201211194908}, DOI={10.2174/1570193X17999201211194908}, abstractNote={
Abstract::
The benzimidazole and its derivatives are privileged heterocyclic motif and important building block for the
development of the biologically active compound. However, several research reports are produced in a short period of time
due to the rapid production of new drugs having a benzimidazole nucleus. In order to understand the current status of the
benzimidazole nucleus in medicinal chemistry science, it is therefore important to combine the latest knowledge with earlier
information. Hence, synthetic organic chemists concentrated on inventing an effective green methodology for
synthesizing benzimidazole derivatives. In addition to this, non-degradable chemical compounds cause the
ecosystem to become fragile, damage or irritation as contaminants and pose a danger to the environment.
However, conventional methods of synthesis need longer heating time, complicated and tedious apparatus set up which
result in high cost and pollution in contrast to greener methods which are inexpensive. In the present review, therefore, we
have attempted to shed light on various synthetic strategies leading to the synthesis of different benzimidazole derivatives
through the direct condensation reaction between o-phenylenediamine and aromatic aldehydes using green chemistry
approaches such as mechanochemistry, ultrasound irradiation, microwave irradiation, environmentally benign
solvents/catalysts, reactant immobilized on a solid support and blue light irradiation.
}, number={8}, journal={MINI-REVIEWS IN ORGANIC CHEMISTRY}, publisher={Bentham Science Publishers Ltd.}, author={Patel, Ashish and Shah, Drashti and Patel, Naiya and Patel, Khushbu and Soni, Nidhi and Nagani, Afzal and Parikh, Vruti and Shah, Hirak and Bambharoliya, Tushar}, year={2021} }
 @article{patel_patel_hemani_solanki_kansara_patel_pradhan_bambharoliya_2021, title={Exploring the in-silico approach for assessing the potential of natural compounds as a SARS-CoV-2 main protease inhibitors}, volume={14}, ISSN={["1307-6175"]}, url={https://publons.com/publon/45416080/}, DOI={10.25135/ACG.OC.97.2012.1895}, abstractNote={The SARS-CoV-2 virus emerged as a major cause of the COVID-19 pandemic in December 2019. Many attempts have been made to block the viral infection by targeting various processes like its entry, uncoating, replication, activating T cells response, and rising antibody titer. Also, many drugs are repurposed like remdesivir, dexamethasone, tocilizumab, hydroxychloroquine based on their established therapeutic efficacy against other viruses in the past. Natural products (NP) consist of a promising candidate and are needed to evaluate those molecules with molecular docking for preliminary screening and in vitro studies. Therefore, in the present study, a total of 12 active constituents from natural products like Ashwagandha, Tinospora cordifolia, Tea, Neem and lemon balm were docked, using the Autodock tool, onto the crystal structure of SARS CoV-2 main protease (PDB ID-5R80), to study their capability to act as main protease (Mpro) COVID-19 inhibitors. All NPs derivatives displayed good binding energies (ΔG) ranging from -8.8 to -5.2 kcal/mol, but berberine, epicatechin, and rosmarinic acid were found most potent, among others. Therefore, good binding energy, drug-likeness, and efficient pharmacokinetics suggest the potential of NPs derivatives as SARS-CoV-2 main protease (Mpro) inhibitors. However, further research is necessary to investigate the ability of these compounds as COVID-19 inhibitors.}, number={1}, journal={ORGANIC COMMUNICATIONS}, author={Patel, Ashish and Patel, Alkesh and Hemani, Rahul and Solanki, Riddhi and Kansara, Janki and Patel, Gargi and Pradhan, Sayantan and Bambharoliya, Tushar}, year={2021}, pages={58–72} }
 @misc{patel_shah_patel_patel_soni_nagai_shah_patel_patel_bhimani_et al._2021, title={Quinoxaline as Ubiquitous Structural Fragment: An Update on the Recent Develop-ment of its Green Synthetic Approaches}, volume={25}, ISSN={["1875-5348"]}, url={https://publons.com/publon/51640511/}, DOI={10.2174/1385272825666211125102145}, abstractNote={

Quinoxaline is a versatile heterocyclic moiety that possesses a wide range of biological
activities. Therefore, many researchers have been performing the synthesis of quinoxaline
derivatives on a daily basis. In addition, high demands for their synthesis often result in an
increased generation of different waste chemicals. However, to minimize the utilization and
generation of toxic organic substances, the present review focuses on the various green synthetic
approaches for the synthesis of quinoxaline and its derivatives. Moreover, due to the
quick manufacturing of novel medications using a quinoxaline scaffold, multiple study reports
are published in a short period of time. Therefore, to fully comprehend the current state of the
quinoxaline scaffold in medicinal chemistry, it is necessary to combine recent findings with
previous understanding. Besides, compared to conventional methods, these green methods
minimize the use and generation of harmful chemicals and improve reaction efficiency in
terms of product yields, purity, energy consumption, and post-synthetic procedures. Therefore, in this review, we
have attempted to shed light on various green synthetic strategies leading to the synthesis of quinoxaline scaffold
and its derivatives, such as ultrasound irradiation, microwave irradiation, grindstone technique, environmentally
benign solvents/catalysts based, and reactant immobilized on a solid support, etc.
}, number={24}, journal={CURRENT ORGANIC CHEMISTRY}, author={Patel, Ashish and Shah, Drashti and Patel, Naiya and Patel, Khushbu and Soni, Nidhi and Nagai, Afzal and Shah, Umang and Patel, Mehul and Patel, Swayamprakash and Bhimani, Bhargav and et al.}, year={2021}, pages={3004–3016} }
 @article{patel_shah_patel_patel_patel_dobaria_shah_patel_chokshi_patel_et al._2021, title={Ultrasound-Assisted One-Pot Synthesis of Tetrahydropyrimidne Derivatives through Biginelli Condensation: A Catalyst Free Green Chemistry Approach}, volume={18}, ISSN={["1875-6255"]}, url={https://publons.com/publon/51640510/}, DOI={10.2174/1570178617999201105162851}, abstractNote={

The aim of present work is one-pot catalyst free green synthesis of tetrahydropyrimidne derivatives
through Biginelli condensation under ultrasonic irradiation.
}, number={9}, journal={LETTERS IN ORGANIC CHEMISTRY}, author={Patel, Ashish and Shah, Jinagna and Patel, Kesha and Patel, Krishna and Patel, Harit and Dobaria, Divyesh and Shah, Umang and Patel, Mehul and Chokshi, Avani and Patel, Samir and et al.}, year={2021}, pages={749–756} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Coronary Artery Disease and The Evolution of Angioplasty Devices}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85127797918&partnerID=MN8TOARS}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={1–62} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Coronary Microvascular Dysfunction (CMD)}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85127816902&partnerID=MN8TOARS}, DOI={10.1007/978-3-030-42443-5_3}, abstractNote={Over the past two decades, coronary microvascular dysfunction (CMD) has emerged as an important mechanism of myocardial ischemia. This chapter describes various pathogenic mechanisms of CMD and explains how CMD can result from functional and/or structural alterations to the vessel wall and lead to varying degrees of disruption to normal coronary physiology. Currently ≈20–50% of patients have a predisposition towards ongoing angina despite successful revascularization surgery. The current goal of percutaneous coronary intervention (PCI) or any other revascularization therapy is to relieve the symptoms rather than address the pathology. It will require new research in this area if an improvement in CMD pathology is to be achieved.}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={11–14} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Definitions and Basic Mechanism of Coronary Artery Disease (CAD)}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85127822516&partnerID=MN8TOARS}, DOI={10.1007/978-3-030-42443-5_2}, abstractNote={Coronary artery disease (CAD) also known as coronary heart disease (CHD) is described as the pathologic process affecting the coronary arteries, while atherosclerotic cardiovascular disease (ASCVD or CVD for short) is referred to as the pathological process affecting the entire arterial circulation, not just the coronary arteries. This chapter defines CAD and CHD along with their atherosclerotic pathogenic pathway and all the factors associated with it. The progression of atherosclerosis and its clinical findings are explained at various stages together with a description of the time course of inflammation and atherosclerotic calcification.}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={3–10} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Diagnosis of Coronary Artery Disease (CAD)}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85127790223&partnerID=MN8TOARS}, DOI={10.1007/978-3-030-42443-5_4}, abstractNote={The evaluation of a patient with known or suspected cardiovascular disease begins with their medical history and a targeted physical examination as well as basic ancillary studies that are sufficient for the physician to understand the aetiology of any chest pain. A history and symptoms of angina are important in order to determine which tools should be used for diagnosis and treatment. This chapter describes the major signs and symptoms associated with cardiac disease. The probability of coronary artery disease (CAD) by age, gender and symptoms are described along with the different types of angina. Invasive and noninvasive techniques that successfully diagnose cardiac disease are also discussed briefly in this chapter. It also includes a comprehensive approach to the diagnosis and treatment of patients with chest pain according to various clinical guidelines. It also lists the established and novel biomarkers for the diagnosis of chronic coronary arterial disease.}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={15–20} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Epidemiology and Risk Factors}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85097422057&partnerID=MN8TOARS}, DOI={10.1007/978-3-030-42443-5_1}, abstractNote={Coronary artery disease (CAD) is a major cause of death and disability in developed countries. Heart disease and stroke are among the top five leading causes of death. This chapter shows the data that CAD is and will continue to become a global burden of disease and, by 2035, nearly half of the US population will have some form of cardiovascular disease (CVD). The American Heart Association has defined seven key risk factors for heart disease and stroke called “Life’s Simple 7”. These are listed in this chapter along with their global impact.}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={1–2} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Evolution of Angioplasty Devices}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85118177686&partnerID=MN8TOARS}, DOI={10.1007/978-3-030-42443-5_6}, abstractNote={It is estimated that 600,000 to 1 million cardiac catheterizations (CC) are performed annually in the United States. This figure exceeds the number of coronary artery bypass graft procedures (CABG) performed on an annual basis, and is expected to grow annually by about 1–5% in the United States. This chapter discusses the evolution in design and development of angioplasty devices including a list of currently available commercial products and experimental designs under research and development. This will enable the reader to get a glimpse of how the medical device sector is attempting to address this major healthcare problem whose total medical costs are expected to reach $1.1 trillion by 2035.}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={31–52} }
 @article{shah_patel_parikh_nagani_bhimani_shah_bambharoliya_2020, title={The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer’s Disease}, volume={19}, url={https://doi.org/10.2174/1871527319666200526144141}, DOI={10.2174/1871527319666200526144141}, abstractNote={

Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) is a rational target in Alzheimer’s
Disease (AD) drug development due to its role in amyloidogenic cleavage of Amyloid Precursor
Protein (APP) in generating Amyloid &#946; (A&#946;). This &#946;-secretase cleaves not only Amyloid Precursor
Protein (APP) and its homologues, but also small series of substrates including neuregulin and
&#946; subunit of voltage-gated sodium channel that play a very important role in the development and
normal function of the brain. Moreover, BACE1 is modulated at the post-translational level by several
factors that are associated with both physiological and pathological functions. Since the discovery of
BACE1 over a decade ago, medicinal chemistry and pharmacokinetics of BACE1 small molecule inhibitors
have proven challenging for the treatment of Alzheimer’s disease.
}, number={3}, journal={CNS & Neurological Disorders - Drug Targets}, publisher={Bentham Science Publishers Ltd.}, author={Shah, Hirak and Patel, Ashish and Parikh, Vruti and Nagani, Afzal and Bhimani, Bhargav and Shah, Umang and Bambharoliya, Tushar}, year={2020}, month={Aug}, pages={184–194} }
 @inbook{king_bambharoliya_ramakrishna_zhang_2020, title={Treatment of Coronary Artery Disease (CAD)}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85127733730&partnerID=MN8TOARS}, DOI={10.1007/978-3-030-42443-5_5}, abstractNote={The treatment of a particular patient’s coronary artery disease (CAD) will depend on the severity of the symptoms and the patient’s pathological condition. In addition to pain, patients may suffer from other symptoms, such as severe fatigue, dyspnea, abdominal pain, nausea and sweating. And in order to understand cardiac pain, one requires knowledge of the interplay between ischemic, metabolic and neurological mechanisms behind CAD. This chapter presents the alternative therapies for stable ischemic heart disease (SIHD) and for acute coronary syndrome (ACS), such as drug therapy, invasive therapy and minimally invasive therapy. Reference is made to the National Institute for Health and Care Excellence (NICE) 2011 respective guidelines, which recommend medical therapy for chronic stable angina and reperfusion therapy for patients with STEMI.}, booktitle={SpringerBriefs in Materials}, author={King, M.W. and Bambharoliya, T. and Ramakrishna, H. and Zhang, F.}, year={2020}, pages={21–29} }
 @inproceedings{bambharoliya_hu_cheng_king_2019, title={Design and development of stent coated with novel cardiac stem cell-mimicking regenerative factors}, volume={40}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85065394023&partnerID=MN8TOARS}, booktitle={Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium}, author={Bambharoliya, T. and Hu, S. and Cheng, K. and King, M.W.}, year={2019}, pages={481} }